Seeing Is Believing
Currently out of the existing stock ratings of Christoph Gretler, 17 are a HOLD (48.57%), 15 are a BUY (42.86%), 3 are a SELL (8.57%).
Analyst Christoph Gretler, currently employed at CREDIT SUISSE, carries an average stock price target met ratio of 57.59% that have a potential upside of 19.52% achieved within 196 days.
Christoph Gretler’s has documented 66 price targets and ratings displayed on 9 stocks. The coverage is on Healthcare, Communication Services, Consumer Cyclical sectors.
Most recent stock forecast was given on ALC, Alcon AG at 18-Aug-2023.
Analyst best performing recommendations are on MED (MEDIFAST INC).
The best stock recommendation documented was for MED (MEDIFAST INC) at 9/26/2022. The price target of $106.61 was fulfilled within 8 days with a profit of $4.44 (4.35%) receiving and performance score of 5.43.
Average potential price target upside
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date of last PT
Price targets met ratio
Average potential upside
Average Days to Hit Target
Performance score
Hold Since 04-Jan-2024
$25.8
$3.55 (15.96%)
2 months ago
(06-Aug-2026)
1/4 (25%)
$1.7 (7.05%)
98
Hold Since 24-Feb-2021
$26
$2.76 (11.88%)
$30
9 months 1 days ago
(05-Jan-2026)
9/16 (56.25%)
$2.22 (9.34%)
215
Hold Since 31-Jul-2024
1 years 1 months 4 days ago
(02-Sep-2025)
0/2 (0%)
$22.96 (132.03%)
Sell Since 23-Feb-2024
1 years 5 months 14 days ago
(22-Apr-2025)
0/5 (0%)
$24.09 (150.28%)
Hold Since 21-Oct-2021
1 years 7 months 10 days ago
(26-Feb-2025)
0/12 (0%)
$26.43 (171.62%)
What Year was the first public recommendation made by Christoph Gretler?